About the Company
We do not have any company description for BIOMERICA INC at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on BIOMERICA INC
Biomerica provides update on inFoods® IBS expansion
IRVINE, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products is pleased to announce advancements in the ...
Shareholders in Biomerica (NASDAQ:BMRA) are in the red if they invested ...
Biomerica, Inc. (NASDAQ:BMRA) shareholders should be happy to see the share price up 16% in the last quarter. But that's small comfort given the dismal price performance over the last year.
Biomerica, Inc. Announces 1-for-8 Reverse Stock Split ... - Nasdaq
Biomerica, Inc. has announced a 1-for-8 reverse stock split of its common stock, set to take effect on April 21, 2025. This measure, approved by stockholders at the 2024 Annual Meeting, aims to ...
Biomerica, Inc. Reports 5% Year-Over-Year Revenue Growth and ... - Nasdaq
Biomerica, Inc. reported a 5% growth in total revenue for the second quarter of fiscal 2025, totaling $1.64 million compared to $1.57 million in the same quarter of the previous year.
Biomerica Launches At-Home Sample Collection for inFoods® IBS ...
Corporate Contact: Zack Irani 949-645-2111 investors@biomerica.com Source: Biomerica, Inc. Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post.
Biomerica Secures Three Key International Patents for inFoods ...
IRVINE, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical technology company, announces they have recently received three patent notices of allowance ...
Medline and Biomerica sign agreement for distribution of Biomerica’s ...
IRVINE, Calif., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced that is has signed a three year agreement with Medline Industries for the distribution of Biomerica’s ...
Biomerica Inc (BMRA-Q) Quote - Press Release - The Globe and Mail
IRVINE, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical technology company, announces they have recently received three patent notices of allowance ...
Biomerica Up on Surge in Diagnostic Medical Tests
Biomerica Inc. has gotten a boost from increased global demand for diagnostic testing. Irvine-based Biomerica, which makes diagnostic-testing products, ranks No. 59 on the list of fastest-growing ...
Biomerica announces the Launch of InFoods IBS as a ... - Morningstar
IRVINE, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced the launch of its InFoods ® IBS test.
Is Biomerica (BMRA) Stock A Buy Or Sell After Q4 Earnings?
Biomerica, Inc. (NASDAQ: BMRA) develops and manufactures diagnostic products focusing on gastrointestinal diseases like irritable bowel syndrome “IBS” and other chronic inflammatory conditions.
Biomerica Launches At-Home Sample Collection for inFoods® IBS ...
Corporate Contact: Zack Irani 949-645-2111 investors@biomerica.com Source: Biomerica, Inc. Source: Biomerica, Inc. 2024 GlobeNewswire, Inc.
Similar Companies
Loading the latest forecasts...